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Abstract
q  .  . The K channel antagonists, glucose 100 mg per mouse i.c.v. , tetraethylammonium 1 mg per mouse i.c.v. and apamin 1 ng per
.  . mouse i.c.v. , reduced food intake of mice comparably to the two anorectic drugs, amphetamine 10 mg per mouse i.c.v. and cocaine 50
. q  .  .mg per mouse i.c.v. . Conversely, the K channel openers, minoxidil 5 mg per mouse i.c.v. and pinacidil 10 mg per mouse i.c.v. ,
 . elicited an orectic effect of the same intensity as that induced by 2-deoxyglucose 200 mg per mouse i.c.v. , aurothioglucose 200 mg per
.  .  .mouse i.c.v. and neuropeptide Y 0.5 mg per mouse i.c.v. . The antisense oligodeoxyribonucleotide 1–3 nmol per injection to mKv1.1
gene produced, at 72 h, a dose-dependent increase in food intake. A quantitative reverse transcription-polymerase chain reaction
 .RT-PCR study demonstrated a reduction in cerebral mRNA levels only in the antisense oligodeoxyribonucleotide-treated group,
indicating the absence of a sequence-independent action. Mice receiving the Kq channel modulators or antisense oligodeoxyribonu-
cleotide had unmodified motor coordination and inspection activity as revealed, respectively, by the rotarod and hole-board tests. The
integrity and functionality of central Kq channels appears, therefore, to be fundamental in the regulation of food intake by mice. q 1997
Elsevier Science B.V.
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1. Introduction
A variety of substances have been demonstrated to
increase a-adrenoceptor agonists, dopamine, opioid pep-
tides, neuropeptide Y, muscimol, acetylcholine, benzodi-
. azepines, etc. or decrease epinephrine, b-adrenoceptor
agonists, dopamine, serotonin, corticotropic releasing fac-
tor, thyrotropin-releasing hormone, bombesin, calcitonin,
calcitonin gene-related peptide, cholecystokinin, insulin,
. etc. feeding after their central administration Morley and
.Levine, 1985 .
The central regulation of food consumption is con-
 .trolled by the hypothalamic cells Morley, 1980 . Electro-
physiological studies have demonstrated that some neu-
rones located in this cerebral area are stimulated by the
enhancement of extracellular levels of glucose Ono et al.,
.1982; Minami et al., 1986 . Different types of neurones
sensitive to glucose have been identified in the guinea-pig
 .ventromedial hypothalamic area Minami et al., 1986 .
)  .  .Corresponding author. Tel.: 39-55 423-7432; Fax: 39-55 436-1613;
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Furthermore, reduced action potential has been observed as
a consequence of glucose injection into the rat lateral
 .hypothalamus Oomura et al., 1969 .
 .  .Ashford et al. 1990a,b,c and Boden et al. 1989 have
reported that the increase in the frequency of hypothalamic
neuronal spiking in rats that follows augmented plasma
glucose levels depends on the inactivation of ATP-depen-
q  .dent K channels K channels .ATP
On the basis of results of the above-mentioned electro-
physiological studies, we thought it worthwhile to investi-
gate the role of K channels in the regulation of foodATP
consumption in mice and to extend the research to the
voltage-dependent Kq channels. To this end both a phar-
macological and an antisense strategy were used. A spe-
cific antisense oligodeoxyribonucleotide, targeting the
translation start region of the mKv1.1 mRNA, was de-
signed. Antisense oligodeoxyribonucleotides are short syn-
thetic DNA segments complementary to sequences of an
mRNA target. By forming DNArmRNA heteroduplexes,
antisense oligodeoxyribonucleotides can transiently inacti-
vate single genes and are, therefore, used both for studies
of gene expression and as potential informational drugs
 .Wahlestedt, 1994 . The effect of intracerebroventricular
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q  .injection of K channel openers minoxidil and pinacidil ,
q K channel antagonists glucose, apamin and tetraethyl-
.ammonium and the mKv1.1 antisense oligodeoxyribonu-
cleotide was evaluated.
2. Materials and methods
2.1. Animals
 . Male Swiss albino mice 23–30 g from Morini San
.Polo d’Enza, Italy were used. The mice were housed 15
per cage. The cages were placed in the experimental room
24 h before the test for adaptation. The animals were kept
at 23"18C with a 12 h lightrdark cycle, light on at 7 a.m.
2.2. Antisense oligonucleotides
The 24mer phosphodiester oligonucleotides were capped
by a terminal phosphorothioate double substitution and
purified by chromatography Genosys, The Woodlands,
.  XTX, USA . The antisense oligodeoxyribonucleotide 5 -
X.CGA CAT CAC CGT CAT GAT GAA AGC-3 was
designed targeting the 5X portion of the murine Kv1.1
 .mKv1.1 mRNA, residues 575–598 of the published
 .cDNA sequence Chandy et al., 1990 . A fully degenerated
24mer oligodeoxyribonucleotide was used as control.
2.3. Administration of antisense oligonucleotide
Mice were randomly assigned to an antisense
oligodeoxyribonucleotide, degenerated oligodeoxyribonu-
cleotide or vector group. 100, 200 and 600 mM
oligodeoxyribonucleotides were preincubated at 378C for
 w  .30 min with 13 mM DOTAP N- 1- 2,3-dioleoyloxy pro-
x .pyl -N, N, N-trimethylammonium methyl sulfate , used as
vector. Each group received a single intracerebroventricu-
 .lar i.c.v. injection on days 1, 4 and 7. The behavioural
tests were performed 72 h after the last i.c.v. injection of
vector or oligodeoxyribonucleotides.
2.4. Administration of drugs
Mice were randomly assigned to a control saline solu-
. tion or a treated aurothioglucose, 2-deoxyglucose, neu-
ropeptide Y, glucose, minoxidil, pinacidil, amphetamine,
.cocaine, apamin, tetraethylammonium group. The mice
were i.c.v. injected with saline or a drug 5 min before the
evaluation of food consumption.
2.5. Intracerebro˝entricular injection technique
Intracerebroventricular administration was performed
under ether anaesthesia using isotonic saline as a solvent,
according to the method described by Haley and Mc-
 .Cormick 1957 . Briefly, during anaesthesia, mice were
grasped firmly by the loose skin behind the head. A 0.4
mm external diameter, hypodermic needle attached to a
10-ml syringe was inserted perpendicularly through the
skull and no more than 2 mm into the brain of the mouse,
where 5 ml was then administered. The injection site was 1
mm to the right or left from the midpoint on a line drawn
through to the anterior base of the ears. Injections were
performed into the right or left ventricle randomly. To
ascertain that the oligodeoxyribonucleotides were adminis-
tered exactly into the cerebral ventricle, some mice were
injected with 5 ml of 1:10 diluted India ink and their brains
were examined macroscopically after sectioning.
2.6. Beha˝ioural tests
2.6.1. E˝aluation of food consumption
Mice did not have access to food for 4 or 12 h but water
was available ad libitum. A weighed amount of food
 .standard laboratory pellets was given and the weight
consumed evaluated as the difference between the original
.amount and the food left in the cage, including spillage ,
was measured 15, 30, 45 and 60 min after injection, to an
accuracy of 0.1 g. An arbitrary cut-off time of 60 min was
used.
2.6.2. Hole-board test
The hole-board test set up consisted of a 40 cm square
plane with 16 flush-mounted cylindrical holes diameter 3
.cm distributed 4 by 4 in an equidistant, grid-like manner.
Mice were placed on the center of the board one by one
and left to move about freely for a period of 5 min each.
Two photoelectric beams, crossing the plane from mid-
point to mid-point of opposite sides, thus dividing the
plane into 4 equal quadrants, automatically signaled the
movement of the animals on the surface of the plane.
Miniature photoelectric cells, in each of the 16 holes,
recorded the exploration of the holes head plunging activ-
.ity by the mice. The test was performed 30 min after i.c.v.
administration of minoxidil and pinacidil, and 60 min after
administration of tetraethylammonium.
2.6.3. Rotarod test
The apparatus consisted of a base platform and a rotat-
ing rod of 3 cm diameter with a non-skid surface. The rod
was placed at a height of 15 cm from the base. The rod, 30
cm in length, was divided into 5 equal sections by 6 disks.
Thus up to 5 mice were tested simultaneously on the
apparatus, with a rod-rotation speed of 16 r.p.m. The
integrity of motor coordination was assessed on the basis
of the number of falls from the rod in 30 s according to
 .Vaught et al. 1985 . Performance time was measured
before and 15, 30 and 45 min after i.c.v. administration of
saline or drugs.
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2.7. In ˝itro studies
2.7.1. RT-PCR-based analysis of mK˝1.1 mRNA
Mouse brain levels of Kv1.1 mRNA were determined
by a quantitative reverse transcription-polymerase chain
 .  .reaction RT-PCR method Quattrone et al., 1995a,b .
Briefly, 72 h after the last i.c.v. injection of vector,
antisense oligodeoxyribonucleotide or degenerated
oligodeoxyribonucleotide, some mice were killed and their
 .brains were rapidly removed and stored y808C . Frozen
 .brain samples 0.2–0.3 g wet weight were homogenised
in 3 volumes of RNAzol in order to extract total RNA
according to the manufacturer’s instructions. RNA was
treated with RQ1 RNase-free DNase, purified by ethanol
precipitation, dissolved in water containing an RNase in-
 .hibitor RNasin at 1 Urml and reversely transcribed to
cDNA using random hexamers. Kv1.1 amplimers were
5X-GCT CTC TCC TGG CCT CCT-3X and 5X-GTT TCG
AAG CGC AGC CCG-3X, residues 544–561 and 715–732
respectively, according to the Kv1.1 cDNA published se-
 .quence Chandy et al., 1990 . b-Actin was used as internal
standard gene. PCR cycles consisted of 1 min denaturation
at 928C, 1 min annealing at 568C and 1 min extension at
728C for 30 cycles. Amplification products were first
identified by sequencing then quantified by densitometry.
2.8. Reagents and drugs
Oligonucleotides used for the antisense strategy, and
specific primers or hexamers used for RT-PCR analysis
 .were from Genosys The Woodlands, USA . DOTAP was
 .from Boehringer-Mannheim Mannheim, Germany . RNA-
 .zol was from Cynna Biotecx Houston, USA ; RQ1
RNase-free DNase, RNase ONE, RNasin, Mo-MLV re-
verse transcriptase and fmol sequencing kit were from
 .Promega Madison, WI, USA ; Taq polymerase was from
 .Perkin-Elmer-Cetus Emeryville, USA . The following
 .drugs were used: aurothioglucose, 2-deoxyglucose Sigma ;
neuropeptide Y, minoxidil, pinacidil, tetraethylammonium
 .  . chloride, apamin RBI ; glucose Merck ; cocaine U.S.L.
.  .10rD, Florence ; D-amphetamine De Angeli .
 .Drugs were dissolved in isotonic NaCl 0.9% saline
solution, with the exception of pinacidil that was dissolved
 .in a water and dimethyl sulfoxide 3 : 1 vehicle, immedi-
ately before use. Antisense and degenerated oligonucleo-
 .tides were dissolved in the vector DOTAP at least 30
min before injection. Drug concentrations were prepared in
such a way that the necessary dose could be administered
in a volume of 5 ml per mouse by i.c.v. injection.
2.9. Sequence and statistical analysis
Sequences of Kv genes are from the GenBank database.
Sequence comparisons of both antisense oligodeoxyribonu-
cleotide and RT-PCR primers with the database were
carried out using the FASTA program. All experimental
results are given as the means"S.E.M. Analysis of vari-
 .ance ANOVA , followed by Fisher’s protected least sig-
 .nificant difference PLSD procedure for post-hoc compar-
ison, was used to verify the significance of differences
between two means of behavioural results. Data were
analysed with the StatView software for the Macintosh
 .1992 . The statistical significance of RT-PCR was ob-
tained using Student’s t-test; P values of less than 0.05
were considered significant.
3. Results
3.1. Food intake
The cumulated amount of food eaten by mice not
deprived of food was compared with that eaten by mice
which had no access to food for 4 or 12 h before the test
 .Fig. 1 . The level of food intake progressively increased
 .up to 45 min 240"14.1 mg per mouse in the 4-h
food-deprived mice and then remained almost unchanged.
The 12-h food-deprived mice had a constant increase in
the amount of food consumed in a 60 min test 630"10
.  .mg per mouse Fig. 1 .
 . Glucose 100 mg per mouse i.c.v. , apamin 1 ng per
. mouse i.c.v. and tetraethylammonium 1 mg per mouse
.i.c.v. significantly reduced food consumption in 12-h
 .food-deprived mice Fig. 2 . The anorectic effect produced
by the above-mentioned drugs was comparable to that
 .exerted by amphetamine 1 and 10 mg per mouse i.c.v.
 .and cocaine 1 and 50 mg per mouse i.c.v. , used as
Fig. 1. Time-course of cumulated food intake in mice after different times
 .0, 4 and 12 h of food deprivation. Mice were i.c.v. injected with saline
solution 5 min before the test. Vertical lines represent S.E.M.; in paren-
theses the number of mice is reported. ) P -0.001 in comparison with
mice not food-deprived.
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 .Fig. 2. Dose-dependent suppression of food intake of 12-h food-deprived mice by glucose, apamin and tetraethylammonium TEA in comparison with
amphetamine and cocaine. Mice were i.c.v. injected with saline solution or a drug 5 min before the test. The food intake values were evaluated as the
cumulated amount of food eaten 60 min after the beginning of the test. Vertical lines represent S.E.M.; the number of mice was between 10 and 20 with
 . ) ) )the exception of saline-treated mice ns85 . P-0.01, P-0.001 in comparison with saline-treated mice.
 .reference drugs Fig. 2 . The food intake values reported in
Fig. 2 were evaluated as the cumulated amount of food
eaten 60 min after the beginning of the test.
Fig. 3 shows the orectic effect of the two Kq channel
 . openers minoxidil 5 mg per mouse i.c.v. and pinacidil 1
.and 10 mg per mouse i.c.v. in mice which were not
provided with food for 4 h. This increase in food consump-
tion was compared with that produced by 2-deoxyglucose
 . 200 mg per mouse i.c.v. and aurothioglucose 200 mg
.per mouse i.c.v. which were used as reference drugs.
Repeated administration of an antisense oligodeoxyri-
bonucleotide to the mKv1.1 gene produced a dose-re-
sponse increase in food consumption by mice after 4 h of
food deprivation, as illustrated in Fig. 4. The dose of
antisense oligodeoxyribonucleotide of 0.5 nmol per i.c.v.
injection was devoid of any orectic effect while the dose of
1 and 3 nmol per i.c.v. injection increased mouse food
intake by, respectively, 82 and 200% in comparison with
 .vector-treated mice Fig. 4 . The degenerated
oligodeoxyribonucleotide did not modify the amount of
Fig. 3. Dose-dependent increase in food intake by mice deprived of food for 4 h after administration of minoxidil and pinacidil in comparison with
2-deoxyglucose, aurothioglucose and neuropeptide Y. Mice were i.c.v. injected with saline solution or a drug 5 min before the test. The food intake values
were evaluated as the cumulated amount of food eaten 30 min after the beginning of the test. Vertical lines represent S.E.M.; the number of mice was
between 10 and 30. ) P-0.001 in comparison with saline-treated mice.
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Fig. 4. Dose-dependent increase in food intake of mice deprived of food
 .for 4 h after antisense oligodeoxyribonucleotide aODN treatment in
 .comparison with that of degenerated oligodeoxyribonucleotide dODN
and vector groups. Mice received a single i.c.v. injection on days 1, 4 and
7. The test was performed 72 h after the last i.c.v. injection. The food
intake values were evaluated as the amount of food eaten 15 min after the
beginning of the test. Vertical lines represent S.E.M.; the number of mice
was between 10 and 20. ) P -0.01, ) P -0.001 in comparison with
vector-treated mice.
food consumed compared to that of the control mice Fig.
.4 .
The food intake values reported in Figs. 3 and 4
corresponded with the maximum effect of minoxidil,
pinacidil and mKv1.1 antisense oligodeoxyribonucleotide
 .that occurred respectively 30 min minoxidil, pinacidil
 .and 15 min antisense oligodeoxyribonucleotide after the
beginning of the test.
3.2. Effect of treatments on mouse beha˝iour
The motor coordination of mice treated with glucose
 . 100 mg per mouse i.c.v. , apamin 0.001 mg per mouse
q Fig. 5. Lack of effect of K channel antagonists, apamin 1 ng per mouse
.  . qi.c.v. and tetraethylammonium TEA, 1 mg per mouse i.c.v. , K
 . channel openers, minoxidil 5 mg per mouse i.c.v. and pinacidil 10 mg
.  .per mouse i.c.v. panel A and an antisense oligodeoxyribonucleotide to
 .mKv1.1 gene panel B in the mouse hole board test. Tetraethylammo-
 .nium TEA , apamin and minoxidil were dissolved in saline solution.
Pinacidil was dissolved in a H OrDMSO 3:1 vehicle. Antisense2
 .oligodeoxyribonucleotide aODN and degenerated oligodeoxyribonu-
 .  .cleotide dODN were dissolved in a vector DOTAP . The number of
mice was between 10 and 16. Vertical lines give S.E.M.
Table 1
q  . q  .Lack of effect of K channel antagonists apamin and tetraethylammonium , K channel openers minoxidil and pinacidil and an antisense
 .oligodeoxyribonucleotide ODN to mKv1.1 gene in the mouse rotarod test
Treatment i.c.v. Number of falls in 30 s
Pre-test After the beginning of the test
15 min 30 min 45 min
Saline 2.8"0.4 2.0"0.5 1.6"0.2 0.8"0.3
Vehicle 2.5"0.2 1.7"0.4 1.6"0.5 1.1"0.2
TEA 1 mg 2.7"0.3 1.7"0.6 1.1"0.2 0.5"0.2
Apamin 0.1 ng 3.6"0.3 2.0"0.5 1.0"0.4 0.8"0.4
Pinacidil 10 mg 2.5"0.4 2.2"0.4 1.7"0.6 1.2"0.3
Minoxidil 10 mg 2.6"0.3 2.0"0.4 1.1"0.3 1.0"0.2
Vector 2.9"0.5 1.9"0.4 1.1"0.4 0.8"0.4
aODN 3 nmol 3.4"0.5 1.9"0.5 1.2"0.4 0.7"0.3
dODN 3 nmol 3.0"0.5 2.0"0.4 1.4"0.4 1.0"0.4
 .Tetraethylammonium TEA , apamin and minoxidil were dissolved in saline solution. Pinacidil was dissolved in a 3:1 H OrDMSO vehicle. Antisense2
 .  .  .ODN aODN and degenerated ODN dODN were dissolved in a vector DOTAP . The number of mice was between 5 and 10.
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.  .i.c.v. , tetraethylammonium 1 mg per mouse i.c.v. , mi-
 . noxidil 10 mg per mouse i.c.v. , pinacidil 10 mg per
. mouse i.c.v. , antisense oligodeoxyribonucleotide 3.0 nmol
.per i.c.v. injection or degenerated oligodeoxyribonu-
 .cleotide 3.0 nmol per i.c.v. injection was evaluated by
using the rotarod test performed starting from 15 min after
the i.c.v. injection of Kq channel modulators or 72 h after
the end of the antisense oligodeoxyribonucleotide treat-
ment. The motor coordination of mice treated with both
potassium channel openers and antagonists or with anti-
sense oligodeoxyribonucleotide was not impaired in com-
parison with that of control mice, since each group pro-
 .gressively reduced its number of falls Table 1 , the mice
having learned how to balance on the rotating rod.
The spontaneous motility and inspection activity of
mice was not modified by the above-mentioned treatments,
as revealed by results of the hole-board test performed 30
min after the i.c.v. injection of minoxidil and pinacidil, 60
min after tetraethylammonium and apamin i.c.v. injection,
or 72 h after the end of the antisense oligodeoxyribonu-
 .cleotide treatment Fig. 5 .
3.3. Effect of antisense oligodeoxyribonucleotide on spe-
cific inhibition of mK˝1.1 gene expression
The lowering of Kv1.1 mRNA following antisense
oligodeoxyribonucleotide administration as an index of
Kv1.1 gene inactivation was quantified by RT-PCR. Quan-
titative results of Kv1.1 mRNA brain levels following
antisense oligodeoxyribonucleotide treatment confirmed
that the observed orectic effect was associated with the
 .specific Kv1.1 mRNA decrease Fig. 6 .
Fig. 6. Quantitative RT-PCR analysis of mKv1.1 mRNA. Following
 .oligodeoxyribonucleotide ODN treatment, total RNA was extracted
from the brains of behaviour-tested mice. mKv1.1 and b-actin mRNA
were submitted to RT-PCR as reported in Section 2. Amplification
products were analysed on agarose gel and quantified by densitometry.
Within the linearity of PCR, the amount of mKv1.1 mRNA relative to
b-actin mRNA was calculated and expressed as percentage of the un-
treated controls. Data are the means of three determinations.
4. Discussion
These studies provide the first reports that the modula-
tion of Kq channel activity influences food intake in mice.
The administration of Kq channel antagonists, such as
glucose, apamin and tetraethylammonium, produced a de-
crease in food consumption. Conversely, the injection of
Kq channel openers, such as pinacidil and minoxidil, as
well as the inhibition of the expression of the mKv1.1 gene
coding for the Kv1.1 Kq channel by using an antisense
strategy, increased the amount of food consumed. The
orectic or anorectic effect produced by Kq channel modu-
lators was of the same magnitude as that produced by well
known orectic 2-deoxyglucose, aurothioglucose and neu-
.  .ropeptide Y and anorectic amphetamine and cocaine
drugs.
Kq channel modulators and antisense oligodeoxyri-
bonucleotide, at the doses used in our experiments, did not
produce any modification of gross behaviour in mice. The
motor coordination, spontaneous motility and inspection
activity of treated mice were not impaired in comparison
with those of the saline and vector groups, making the
results obtained reliable. Higher doses of apamin were not
investigated since, starting at the dose of 3 ng per mouse
i.c.v., convulsions were elicited. For all other Kq channel
modulators used, the highest doses reported represent the
doses at which the maximum effect was reached.
When considering the described sequence-independent,
non-antisense effects of oligodeoxyribonucleotides Storey
et al., 1991; Gao et al., 1992; Blagosklonny and Neckers,
.1994; Schick et al., 1995 , a fully degenerated phosphodi-
ester-phosphorothioate capped oligodeoxyribonucleotide
was used as the most suitable control for these potentially
confusing effects. The fully degenerated 24mer is a collec-
tion of about 3=1014 different molecular species, so that
for the nanomolar–micromolar range concentrations
achieved in in vitro antisense experiments, every species,
i.e. every oligodeoxyribonucleotide of defined sequence,
was present at the site of action at a sub-attomolar concen-
tration that is totally insufficient to achieve any antisense,
or generally sequence-dependent, cellular effect. There-
fore, if oligodeoxyribonucleotide i.c.v. administration per
se had produced any biological response, this would have
been present in degenerated oligodeoxyribonucleotide-
treated controls. The degenerated oligodeoxyribonucleotide
treatment did not modify mouse food intake in comparison
with vector i.c.v. injected mice. This observation ruled out
the possibility that the antagonism exerted by antisense
oligodeoxyribonucleotide could be due to a sequence-inde-
pendent action on cerebral structures. The validity of this
hypothesis was further supported by results of a quantita-
tive RT-PCR study demonstrating a reduction in mKv1.1
mRNA levels only in the antisense oligodeoxyribonu-
cleotide-treated group.
All drugs were injected directly into the cerebral ventri-
cles in order to focus the investigation on the central
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nervous system and, therefore, to avoid interference from a
peripheral mechanism.
The anorectic effect of glucose, apamin and tetraethyl-
ammonium was evaluated in mice deprived of food for 12
h. These experimental conditions were needed to better
evidence a reduction in food intake. On the other hand, to
investigate the orectic effect of minoxidil and pinacidil,
mice not deprived of food should be used. Since no
significant modification of food consumption was ob-
served in mice having free access to food, food deprivation
for 4 h was necessary to evaluate the orectic effect of the
two Kq channel openers.
The possible involvement of K in the regulation ofATP
food intake was postulated based on electrophysiological
 .studies see Section 1 . The present experiments not only
confirmed the role of K in mouse feeding behaviour byATP
means of a behavioural test, but also extended the investi-
gation to the role of other Kq channel subtypes, such as
voltage-dependent Kq channels, in the modulation of food
consumption. The mouse Kv1.1 is a Kq channel of the
Shaker-like subfamily that, when expressed in Xenopus
oocytes, gives rise to a fast-activating, slowly inactivating
q  .K current Hopkins and Tempel, 1992 . The investigation
into the involvement of mKv1.1 in mouse feeding was
carried out because of its wide distribution in the mam-
malian brain, including areas that are involved in the
 .regulation of food intake Wang et al., 1994 . The expres-
sion of the mKv1.1 gene was inhibited by using a specific
antisense oligodeoxyribonucleotide and this produced a
dose-dependent orectic effect. Antisense oligodeoxyri-
bonucleotides specifically bind to targeted mRNA, pre-
venting translation andror mediating mRNA cleavage by
RNase H and, therefore, down-regulating the synthesis of
the encoded protein. Low cell permeability and the high
degradation of natural phosphodiester oligomers are con-
siderable drawbacks of the application of antisense
oligodeoxyribonucleotides both in vitro and in vivo. In
order to overcome these drawbacks, phosphorothioate-
capped phosphorodiester oligonucleotides, a class of
oligodeoxyribonucleotide derivatives that has been shown
to maintain more stable and effective concentrations in the
brain than do their unmodified counterpart Whitesell et
.al., 1993 , were used. Furthermore, both oligodeoxyri-
bonucleotide stability and cell uptake are enhanced when
oligodeoxyribonucleotides are associated with an artificial
 .cationic lipid DOTAP used as an intracellular carrier
 .Capaccioli et al., 1993; Quattrone et al., 1994 .
The anti-mouse Kv1.1 antisense oligodeoxyribonu-
cleotide was designed by comparing the sequence of the
translation start sites of mRNAs to the murine Kv1.1
cDNA and other known Kq channel coding genes, consid-
ering that this site is particularly prone to antisense
oligodeoxyribonucleotide action Goodchild, 1989; Stein
. Xand Cheng, 1993 . The 24-bp segment, 5 -GCT TTC ATC
X ATG ACG GTG ATG TCG-3 residues 575–598 of the
published mouse Kv1.1 cDNA sequence; Chandy et al.,
.1990 , has a low sequence homology even with the nearest
members of the Shaker-like subfamily 54% with Kv1.2,
.Kv1.3, Kv1.4 and is almost totally unrelated to members
of other Kv gene subfamilies. The antisense oligodeoxyri-
bonucleotide used, which is complementary to this Kv1.1
mRNA segment, is therefore most probably unable to
target other mouse Kv mRNAs. Moreover, this antisense
oligodeoxyribonucleotide has terminal GCs at both the 5X-
and 3X-end, known to enhance the binding affinity of
antisense oligodeoxyribonucleotidermRNA heterodu-
plexes.
The present results not only indicate the possible impor-
tance of K and mKv1.1 in the regulation of food intakeATP
of mice, but also confirm the usefulness of antisense
strategies for in vivo investigation. Moreover, the similar-
ity between results obtained with antisense oligodeoxyri-
bonucleotide and Kq channel openers indicates that the
lack of the Kv1.1 channel seems to be equivalent to their
opening, at least from the orectic point of view.
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